2232 related articles for article (PubMed ID: 25442858)
1. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
[TBL] [Abstract][Full Text] [Related]
3. Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA.
Cho H; Kim YW; Suh CH; Jung JY; Um YJ; Jung JH; Kim HA
Lupus; 2016 Oct; 25(12):1341-8. PubMed ID: 26985011
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
[TBL] [Abstract][Full Text] [Related]
5. The association of smoking with IGRA and TST results in HIV-1-infected subjects.
Aichelburg MC; Mandorfer M; Tittes J; Breitenecker F; Reiberger T; Rieger A; Kohrgruber N
Int J Tuberc Lung Dis; 2014 Jun; 18(6):709-16. PubMed ID: 24903943
[TBL] [Abstract][Full Text] [Related]
6. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
[TBL] [Abstract][Full Text] [Related]
7. Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia.
Chkhartishvili N; Kempker RR; Dvali N; Abashidze L; Sharavdze L; Gabunia P; Blumberg HM; Del Rio C; Tsertsvadze T
BMC Infect Dis; 2013 Nov; 13():513. PubMed ID: 24176032
[TBL] [Abstract][Full Text] [Related]
8. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
[TBL] [Abstract][Full Text] [Related]
9. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
[TBL] [Abstract][Full Text] [Related]
10. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
Yilmaz N; Zehra Aydin S; Inanc N; Karakurt S; Direskeneli H; Yavuz S
Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A Meta-Analysis.
Ayubi E; Doosti-Irani A; Sanjari Moghaddam A; Sani M; Nazarzadeh M; Mostafavi E
PLoS One; 2016; 11(9):e0161983. PubMed ID: 27622293
[TBL] [Abstract][Full Text] [Related]
12. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.
Dorman SE; Belknap R; Graviss EA; Reves R; Schluger N; Weinfurter P; Wang Y; Cronin W; Hirsch-Moverman Y; Teeter LD; Parker M; Garrett DO; Daley CL;
Am J Respir Crit Care Med; 2014 Jan; 189(1):77-87. PubMed ID: 24299555
[TBL] [Abstract][Full Text] [Related]
13. Role of QuantiFERON(®)-TB Gold In-Tube in tuberculosis contact investigation: experience in a tuberculosis unit.
Gonzślez-Moreno J; García-Gasalla M; Gállego-Lezaun C; Fernández-Baca V; Mir Viladrich I; Cifuentes-Luna C; Serrano Bujalance A; Salom Vallespir A; Payeras Cifre A
Infect Dis (Lond); 2015 Apr; 47(4):244-51. PubMed ID: 25692351
[TBL] [Abstract][Full Text] [Related]
14. Predictors of discordant tuberculin skin test and QuantiFERON®-TB Gold In-Tube results in various high-risk groups.
Weinfurter P; Blumberg HM; Goldbaum G; Royce R; Pang J; Tapia J; Bethel J; Mazurek GH; Toney S; Albalak R;
Int J Tuberc Lung Dis; 2011 Aug; 15(8):1056-61. PubMed ID: 21740668
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and incidence of latent tuberculosis infection in georgian healthcare workers.
Whitaker JA; Mirtskhulava V; Kipiani M; Harris DA; Tabagari N; Kempker RR; Blumberg HM
PLoS One; 2013; 8(3):e58202. PubMed ID: 23536789
[TBL] [Abstract][Full Text] [Related]
16. Association of clinical properties and compatibility of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test in patients with psoriasis.
Karataş Toğral A; Muştu Koryürek Ö; Şahin M; Bulut C; Yağci S; Ekşioğlu HM
Int J Dermatol; 2016 Jun; 55(6):629-33. PubMed ID: 26498894
[TBL] [Abstract][Full Text] [Related]
17. The performance of quantiferon-TB gold in-tube (QFT-IT) test compared to tuberculin skin test (TST) in detecting latent tuberculosis infection (LTBI) in the presence of HIV coinfection in a high TB-burden area with BCG-vaccinated population.
James PM; Ganaie FA; Kadahalli RL
J Int Assoc Provid AIDS Care; 2014; 13(1):47-55. PubMed ID: 23482341
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation.
Moon SM; Lee SO; Choi SH; Kim YS; Woo JH; Yoon DH; Suh C; Kim DY; Lee JH; Lee JH; Lee KH; Kim SH
Transpl Infect Dis; 2013 Feb; 15(1):104-9. PubMed ID: 22823749
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis skin test, but not interferon-γ-releasing assays is affected by BCG vaccination in HIV patients.
Wolf T; Goetsch U; Oremek G; Bickel M; Khaykin P; Haberl A; Bellinger O; Gottschalk R; Brodt HR; Stephan C
J Infect; 2013 Apr; 66(4):376-80. PubMed ID: 23159357
[TBL] [Abstract][Full Text] [Related]
20. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
